The information contained within this announcement is deemed
by the Company to constitute inside information as stipulated under
the Market Abuse Regulations (EU) No. 596/2014 as amended by
regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations
2019/310. Upon the publication of this announcement
via Regulatory Information Service, this inside information is
now considered to be in the public domain.
5 December 2024
Marlowe
plc
Interim results for the six
months to 30 September 2024
Marlowe is now focussed on
the highly attractive and regulated business-critical service
markets across its Testing, Inspection & Certification
businesses and has delivered performance in line with
expectations
All integration programmes
and restructuring investments now concluded in line with market
guidance and no further restructuring investments expected in the
second half of the year
Marlowe plc ("Marlowe", the "Group" or the "Company"), a leading testing, certification and inspection service
provider, announces its interim results for the six months ended 30
September 2024 ("HY25").
On 3 June 2024, the Group
announced the completion of the sale of certain Governance, Risk
& Compliance ("GRC")
software and services assets ("Divestment") for an Enterprise Value of
£430 million in cash. Subsequently, on 12 September 2024, the Group
announced the demerger of its Occupational Health division
("Demerger") and subsequent
registration as a separate public limited company under the name
Optima Health plc.
Marlowe's continuing operations
since 23 September 2024 now comprise the Testing, Inspection &
Certification ("TIC")
division on which the Group's forward strategy is
focussed.
Financial performance
ADJUSTED RESULTS - CONTINUING OPERATIONS
|
HY25
|
HY24
|
Change
|
|
|
|
|
Revenue
|
£151.7m
|
£146.3m
|
+4%
|
Adjusted
EBITDA1,2
|
£15.3m
|
£15.4m
|
(1)%
|
Adjusted EBITDA margin1,2
|
10.1%
|
10.5%
|
(40)bps
|
Adjusted operating
profit2
|
£9.0m
|
£9.7m
|
(7)%
|
Adjusted earnings/(loss) per share
- basic2
|
6.4p
|
5.4p
|
+19%
|
|
|
|
|
Net cash/(debt) (excluding lease
liabilities)
|
£30.8m
|
£(192.7)m
|
|
STATUTORY RESULTS - CONTINUING OPERATIONS
|
HY25
|
HY24
|
|
|
|
Revenue
|
£151.7m
|
£146.3m
|
Operating
profit/(loss)3
|
£3.4m
|
£(5.9)m
|
Profit/(loss) before
tax3
|
£2.4m
|
£(8.7)m
|
Earnings/(loss) per share
- basic3
|
2.5p
|
(9.3)p
|
STATUTORY RESULTS - GROUP
|
HY25
|
HY24
|
|
|
|
Revenue
|
£220.4m
|
£251.3m
|
Operating
loss3
|
£(0.9)m
|
-
|
Profit/(loss) before
tax3
|
£161.7m
|
£(8.9)m
|
Earnings/(Loss) per share
- basic3
|
174.4p
|
(9.6)p
|
|
|
|
Net cash/(debt)
|
£9.2m
|
£(219.4)m
|
1 Earnings before interest,
taxes, depreciation and amortisation ("EBITDA")
2 Explanation of non-IFRS
measures are contained within the Financial Review and note 2 and
3
3 Further details shown in
consolidated statement of comprehensive income
STRATEGY AND TRADING PERFORMANCE - CONTINUING
OPERATIONS
A
leading TIC service provider
· Marlowe's forward-looking strategy is to focus on the highly
regulated business-critical service markets across TIC with strong
recurring revenues based on non-discretionary customer spend and
underpinned by regulatory and insurance requirements
· Following completion of the Demerger, the primary focus in
the near term remains on driving margin enhancement and organic
growth
· The
TIC service markets do however remain highly fragmented, and
bolt-on acquisitions continue to present an attractive route to
delivering additional shareholder value
· The
Group's TIC division is expected to deliver approximately £325
million of revenue and adjusted EBTIDA in the region of £40 million
for the 12-month period to 30 September 2025, Head Office costs are
expected to be £4 million over that 12-month period
Strategic review creating significant shareholder
value
· Following the strategic review announced in November 2023,
the Company completed the Divestment on 3 June 2024 for an
enterprise value of £430 million
· The
Group has since returned an aggregate of approximately £200 million
to shareholders, with £150.3 million via a special dividend,
equating to £1.55 per ordinary share, paid on 5 July 2024 and good
progress made on the share buyback programme which commenced on the
same day, returning a further £51.0 million to shareholders as at 2
December 2024
· In
addition to the Divestment, the Group subsequently completed the
Demerger of its Occupational Health activities ("OH") on 23
September 2024, creating a separate public limited company under
the name Optima Health plc
· Marlowe's Board will continue to execute the delivery of the
Group's strategy while regularly evaluating ways to further
maximise shareholder value
FINANCIAL REVIEW - CONTINUING OPERATIONS
· Revenue from continuing
operations up 4% to £151.7 million
o Organic growth of
3%[1] reflecting mid-single digit growth
in Fire Safety & Security and low single digit growth in Water
& Air Hygiene
· Adjusted EBITDA from
continuing operations was £15.3 million (HY24: £15.4
million)
o Adjusted EBITDA margins
decreased 40bps to 10.1% (HY24: 10.5%)
o Whilst the Group achieved
good margin enhancement in its Fire Safety & Security business,
there were margin decreases in our Water & Air Hygiene business
as a result of the implementation of operational processes that
will deliver in the longer term
o Head office costs during the
period were £2.8 million (HY24: £2.6 million) and the Group aims to
reduce this further
o Divisional adjusted EBITDA
margins are expected to improve, and the Board has a medium-term
target of 15% as we focus on operational efficiencies and revenue
mix
· Statutory operating profit
from continuing operations was £3.4 million
(HY24 Statutory operating loss of £(5.9) million)
as a result of the significant reduction
in adjusting items including restructuring and acquisition
costs
FINANCIAL REVIEW - THE GROUP
· Group revenue, including
discontinued operations, decreased 12% to £220.4
million reflecting the Divestment
and the Demerger in the period
· Statutory profit before tax
of £161.7 million (HY24: loss before tax of £8.9
million)
o The increase in the period
primarily reflects the £165.9 million profit on the
Divestment
o Total finance costs of £3.3
million (HY24: £8.9 million) comprises the utilisation of the prior
debt facility for the first two months of the period, which was
fully settled following the Divestment, and IFRS 16 lease interest
largely residing in the continuing operations
· Statutory earnings per share
of 174.4 pence (HY24: loss per
share 9.6 pence)
· Strong balance
sheet
o Net cash (excluding leases)
at 30 September 2024 was £30.8 million (30 September 2023 net debt
(excluding leases) of £192.7 million). The movement reflects the
£430 million Divestment, settlement of the old debt facility,
payment of the £150.3 million special dividend and the good
progress made on the share buyback programme in the
period
o The Group generated £6.4
million of cash from both discontinued and continuing operations in
the period before interest and tax (HY24 of £16.7 million). This is
after £14.2 million of costs relating to the Divestment, the
Demerger and restructuring
o
· Successful execution of
integration programme
o Finalised integration
programmes with all costs associated with
restructuring investments now concluded in line with market
guidance
CURRENT TRADING AND OUTLOOK
· The
Board remains focussed on ensuring the forward-looking strategy
maximises shareholder value
· Marlowe operates in highly attractive and regulated
business-critical service markets across TIC
· No
further restructuring costs expected in the second half of the
year
· We
have continued to make good progress with the ongoing share buyback
programme. Since the 30 September 2024 we have returned an
additional £10.0 million to shareholders acquiring 2.9 million
ordinary shares as at 4 December 2024. The Group has now returned
an aggregate £51.0 million to shareholder as part of this
programme
· The
recently announced UK Autumn Budget 2024 is likely to have an
impact on margins in the near term, but we are confident we can
mitigate these additional costs in the medium term through pricing
and operational efficiencies
· The
primary focus continues to be on driving organic growth while
improving margins and delivering attractive free cash
flow
Lord Ashcroft, Interim Non-Executive Chair,
commented:
"The Group has undergone significant change in the period to
focus on the attractive TIC market, having completed the Divestment
of certain GRC software and service assets for £430 million in June
and subsequently demerging its Occupational Health division in
September 2024."
"Marlowe's business now consists of the market leading
compliance service TIC division which comprise the Fire Safety
& Security and Water & Air Hygiene businesses. The Group
has a strong balance sheet and is well positioned to drive organic
growth, margin enhancement and strong cash
generation."
"Marlowe has today published an interim results presentation
which has been made available on the Marlowe plc
website."
For further information:
|
|
|
|
Marlowe plc
|
|
Lord Ashcroft, Interim
Non-Executive Chair
Adam Councell, Chief Financial
Officer
Benjamin Tucker, Head of Group
Reporting
|
www.marloweplc.com
0203 813 8498
IR@marloweplc.com
|
Cavendish Capital Markets Limited (Nominated Adviser &
Broker)
|
Ben Jeynes
George Lawson
|
0207 220 0500
|
|
|
FTI Consulting
|
0203 727 1340
|
Nick Hasell
Alex Le May
|
|
BUSINESS REVIEW
This has been a significant period
of change for Marlowe. In November 2023, we announced a review of
the Group's structure as it had become clear that the operational
activities of the Group had diversified into sectors with varying
operational and financial characteristics.
Following the announcement of the
strategic review we received an offer for a number of our GRC
software and service assets. Consequently, in February 2024, we
announced a binding agreement for these assets for an enterprise
value of £430 million, a valuation that represented the 121% of
Marlowe's market capitalisation on the day prior to the
announcement.
On 3 June 2024 we announced the
completion of the Divestment and the intention to return of up to
£225 million of proceeds to shareholders, comprising a £150 million
special dividend and a share buyback programme of up to £75
million. During the period we retired the Group's debt facility and
on 5 July 2024 returned £150.3 million via a special dividend,
which equated to £1.55 per ordinary share, and initiated the share
buyback programme.
Moreover, on 12 September 2024,
the Group announced the demerger of its Occupational Health
division to be registered as a separate public
limited company under the name Optima Health plc. The Demerger will
allow Marlowe, as a market-leading TIC business and Optima
Health, as the UK's leading provider of technology
enabled corporate health and wellbeing solutions, as two distinct
listed entities and will enable each to fully focus on their
respective end markets and future strategic objectives.
The continuing TIC operations
comprise the Fire Safety & Security and the Water & Air
Hygiene businesses. These operations are focussed on ensuring the
safety and compliance of customers' business premises in accordance
with relevant regulation and legislation and serve approximately
27,000 customers across the UK. The TIC sector was the
first market Marlowe entered and where it made its original
acquisitions in 2016. This sector continues to display the same
attractive structural growth drivers which are underpinned by
regulation, legislation and high levels of recurring
income.
We continue to see significant
opportunity for further organic growth as we look ahead
supplemented by selective acquisitions. In the near term we are
focussed on driving organic revenues, improving margins and
delivering attractive free cash flow. We have a refocused strategy
and are well positioned to capitalise on the attractive TIC service
markets we serve.
Financial results - continuing operations
The Group performed in line with
expectations for the six months ended 30 September 2024. Revenue
from continuing operations grew 4% to £151.7 million benefiting
from 3% organic growth and a small contribution from acquisitions
made at the start of prior period.
Adjusted EBITDA, in a period of
significant integration focus and transformation was £15.3 million
(HY24: £15.4 million). Adjusted EBITDA margins in TIC decreased to
11.9% (HY24: 12.3%) as a result of a period of operational change
in our main Water & Air Hygiene business where we have focussed
on putting in place operational processes that will deliver in the
longer term, so we are well positioned to successfully drive
margins. This margin reduction was partially offset by good margin
enhancement in our Fire Safety & Security business as we
successfully transitioned work from subcontractors to in-house
fee-earners and benefit from our integration investments. We expect
our TIC division to deliver adjusted EBITDA margin improvements
with a medium-term target of 15% as we focus on delivering
operational efficiencies and improving revenue mix.
Statutory profit before tax for
the Group was £161.7 million (HY24 loss before tax: £8.9 million),
with the improvement resulting from the profit on the Divestment in
the period and a reduction in adjusting items.
The continuing businesses of Fire
Safety & Security and Water & Air Hygiene are both highly
cash generative and free cash flow is a key metric that both the
Board and management are focussed on. The Group, including
discontinued operations, generated £6.4 million of cash from
operations after £14.2 million of acquisition and restructuring
costs as we have focussed on finalising integration
programmes.
Attractive and resilient business model
The compliance markets we serve
are underpinned by regulation and are therefore predominantly
non-discretionary to our customers and are required throughout the
economic cycle. An estimated 75% of our revenues are recurring with
customers typically contracted on 3-to-5-year agreements, providing
us with secure and highly visible revenue streams.
Both of our markets have
structural growth characteristics and benefit from onerous and
evolving regulations with increasing enforcement action from
regulators. Compliance spending continues to grow at attractive
rates from the increasing focus on health & safety and growing
insurance requirements.
Since entering the TIC markets in
2016, Marlowe has built significant scale and expanded its range of
services. This growth has become a key differentiator, enabling us
to deliver services across all UK postcodes and address the needs
of complex and larger multi-site customers. Currently, 90% of our
27,000-strong customer base comprises organisations with complex or
multi-site operations, a segment that smaller and mid-sized
competitors are unable to serve effectively.
Our customer profile aligns with
broader trends in the professionalisation of procurement. Smaller
sites are increasingly being consolidated under multi-site
operations, often managed by centralised procurement teams and
property management firms. These organisations place a heightened
focus on compliance, regulatory adherence and insurance
requirements and this focus positions Marlowe well to be a provider
of choice.
Strong balance sheet and disciplined approach to capital
allocation
Adjusted net cash (excluding
leases) was £30.8 million as at 30 September 2024 from an adjusted
net debt position of £176.6 million as at 31 March 2024. This
follows the £430 million Divestment, settlement of the old debt
facility, the return of capital via £150.3 million special dividend
and £41.0 million via the share buyback programme in the period.
This was supplemented by good cash generation in the
period.
On 24 June 2024, the Group entered
into a new unsecured 3-year Revolving Credit Facility ("RCF") of
£50 million with an uncommitted accordion facility of £50 million,
and these facilities are currently undrawn.
The Board anticipates that the
Group's strong cash generation will be used either to return
further capital to shareholders or, when appropriate, invest in
bolt-on acquisition opportunities across TIC.
Strengthening and integrating
We have made significant
operational progress on continuing operations in the period and
restructuring activity and associated costs have now concluded. We
have built the clear market leader in Water & Air Hygiene and
are a top 3 player in Fire Safety & Security. During the
period, we placed a significant focus on finalising restructuring
costs and invested £2.1 million (HY24: £4.1 million) into
restructuring, below of our £5 million target.
Marlowe's primary focus in the
near term remains on driving operational efficiency and organic
growth across these integrated platforms within the highly
attractive and defensive TIC markets while driving strong cash
conversion.
Outlook
The second half of the year has
started in line with the Board's expectations, and we continue to
see strong demand for our TIC services. The Group is focused on
driving margin enhancement and expects to deliver high single digit
adjusted EBITDA growth.
The recently announced UK Autumn
Budget 2024 is expected to put a temporarily pressure on margins
through the delay in recovering the increase in National Insurance
costs and we are expecting some impact on project lead times
through greater customer hesitancy. We are confident that through
pricing and operational efficiency we will be able to mitigate this
impact and continue to aim to expand margins in medium
term.
Looking forward, the Group's TIC
division is expected to deliver £325 million of revenue and
adjusted EBTIDA in the region of £40 million for the 12 month
period to 30 September 2025. Head office
costs are expected to be £4 million. In the absence of any future
acquisitions, the Group expects no further restructuring
costs.
The Board retains the flexibility
to use the remaining net cash proceeds from the Divestment
alongside the Group's strong cash generation to return further
return capital or to pursue carefully selected bolt-on acquisitions
where appropriate.
TESTING, INSPECTION AND CERTIFICATION
Revenue increased 4%, reflecting
organic growth of 3% in the period and a small contribution from
acquisitions made at the start HY24. Adjusted EBITDA was £18.0
million resulting in margins decreasing by 40 basis
points.
Fire Safety &
Security, which represents nearly half of
divisional revenues, delivered mid-single digit organic growth and
high single digit organic EBITDA growth.
The primary fire installation and
service business, representing around two thirds of the
subdivision's revenues, delivered good organic growth with rising
productivity, reaching a revenue per day per fee-earner of up to
£700. Growth was also driven by the kitchen fire suppression
business where our innovative interlock solution is helping
businesses meet new regulatory requirements. Although performance
in the passive fire segment was weaker, we have addressed this by
appointing the new leadership and implementing structural changes
that position us well in this growing market.
During the period, we undertook a
review of key contracts supported by the strong emphasis placed on
improving our data analytics to optimise customer profitability.
This shift away from historical less profitable contracts has led
to some short-term revenue impact, but it has been a key driver in
achieving strong EBITDA margin growth by redeploying our
fee-earners to higher-margin opportunities.
Restructuring costs in the period
amounted to £1.2 million, as we finalised the integration of
acquisitions completed in the prior year. While some recently
acquired businesses posed initial challenges, we have taken
decisive steps to address these and are confident in recovery in
the second half. Subcontractor usage, which was a focus area in
FY24, has now normalised, contributing further to margin
improvement.
Our investment in employee
training via Marlowe Academy has been a success, evidenced by
improved retention and reduced dependency on external talent.
Trainee hires are able to serve customers within 14 weeks, allowing
our experienced engineers to focus on more complex jobs, driving
efficiency, customer service and EBITDA growth. We continue to
benefit from strong customer retention rates, with compliance rates
at a best in class 98% (FY24), first time
fix rates increasing to 78% and a zero tolerance focus on customer
compliance backlog. Specific sector development strategies over the
past two years on critical national infrastructure has resulted in
a record project install order book that has more than double in
the last 18 months.
The second half of the year has
started well, with organic growth expected to continue in the
mid-single digits, supported by margin enhancements. Our new
scheduling system, set for FY26 rollout, is designed to further
improve revenue per fee-earner per day, operation efficiency and
customer response KPIs. While the recently announced UK Autumn
budget will affect near-term margins, we are confident in our
ability to mitigate these costs through efficiencies and pricing in
the medium term.
The Water & Air Hygiene sub-division,
accounting for just over half of the division's revenues, delivered
mid-single-digit organic revenue growth, however EBITDA margins
contracted.
The primary water business, which
accounts for approximately 40% of sub-divisional revenue, remains a
key focus for the divisional management team. We are actively
aligning key systems and processes within this segment to enhance
performance. While these efforts have temporarily impacted margins
in the period, we are now showing improvements and are confident
that the actions taken will unlock significant opportunities for
margin improvement through enhanced operational and process
efficiencies. Additionally, the Air business, which represents
approximately 5% of divisional revenues, experienced a decline due
to employee attrition caused by competitive industry dynamics
earlier in the year. These challenges have since
stabilised.
The environmental engineering
business, which specialises in designing and installing wastewater
equipment for sewage and industrial wastewater and represents
around 20% of sub-divisional revenues, performed strongly and
delivered high-teens revenue growth. This performance reflects our
strong market reputation and our ability to swiftly meet customer
needs through our extensive expertise.
The remaining elements of our
Water and Air business consist of our training, asbestos and
chemicals businesses. Our training business, while a smaller
contributor to revenues, posted mid-teens organic growth. This
growth highlights our increased emphasis on offering training
services to both external engineers and existing customer as we
leverage our best-in-class training facilities. The asbestos
business performed in line with expectations, and the chemical
business remained largely level as we manage commodity pricing well
in a changing market.
The Water & Air Hygiene
sub-division has undergone a significant transformation. This
sub-division is now unified under the lead brand Marlowe
Environmental Services which has allowed us to market our broad
range of services more effectively and has been well received by
customers, suppliers and our people. Our integration efforts in
this business have resulted in advanced governance and improved
learning & development enabling us to address skills shortages
in the market more effectively. Driven by the success of the Fire,
Safety & Security trainee programme, we are replicating this
initiative with Water & Air Hygiene. We have seen a significant
step change in employee engagement and are starting to see a
positive impact on retention.
Restructuring costs, as with Fire
Safety & Security, have now ceased. During the period we
incurred £0.9 million of restructuring costs. Over the past six
years, these investments have established us as the clear UK market
leader in this sector whilst maintaining best in class (98%)
compliance rates on national level. We are well positioned to
continue to unlock additional customer spend through an expanded
multi-product and service offering. Additionally, improved data
capture is driving more effective cross-selling opportunities
between Water & Air Hygiene and the Fire Safety & Security
division.
The second half of the year has
begun in line with expectations, with mid-single-digit organic
growth anticipated, supported by margin enhancements.
However, the Autumn 2024 Budget is expected to
put a temporary pressure on margins and we are expecting some
impact on project lead times within our engineering business. We
are confident that medium-term mitigation strategies, including
pricing and operational improvements, will offset these challenges
and drive margin expansion.
FINANCIAL REVIEW
Overview
Revenue decreased 12% in period to
£220.4 million (HY24: £251.3 million) as a result of the Divestment
which completed in the period.
Statutory profit before tax was
£161.7 million (HY24 loss before tax: £8.9 million) largely
reflecting the £165.9 million profit recognised from the
Divestment. The profit recognised from the Divestment is not
subject to corporation tax due to substantial shareholder exemption
with the exception of IMSM which was acquired within 12 months of
the binding agreement for the assets. Statutory basic earnings per
share was 174.4 pence (HY24 loss per share of 9.6
pence).
Acquisition and disposal costs
increased to £10.8 million (HY24: £5.5 million) reflecting both the
Divestment and Demerger that took place in the period. These costs
are one-off in nature and will not continue into the second half.
Finance costs decreased to £3.3 million (HY24: £8.9 million) and
reflects the utilisation of the previous debt facility for the
first two months of the period before repaying in full and retiring
the facility. This has since been replaced with a
£50 million RCF which is currently undrawn. Other
adjusting items in the first half of the year included the
amortisation of acquired intangibles, share-based payments and
other non-trading items.
Following the Divestment in the
first half of FY25 and the Demerger of the Occupational Health
division, our financial results for the first half of FY24 have
been restated to classify these businesses as discontinued
operations. The rest of this report is therefore mainly focused on
our continuing operations which comprise the TIC division and head
office costs.
Revenue from continuing operations
increased by 4% to £151.7 million (HY24: £146.3 million), with a
statutory operating profit of £3.4 million compared to a statutory
operating loss of £5.9 million in the comparable prior period.
Adjusted EBITDA from continuing operations was £15.3 million (HY24:
£15.4 million), reflecting the impact of operational changes in our
water business that affected margins. However, this was offset by
strong growth in our Fire, Safety & Security segment, driven by
the benefits of recent integration investments.
Non-IFRS measures
IFRS measures ensure that the
financial statements contain all the information and disclosures
required by all accounting standards and regulatory obligations
that apply to the Group. The financial statements also include
measures which are not defined by generally accepted accounting
principles such as IFRS. We believe this information, along with
comparable IFRS measures, is useful as it provides investors with a
basis for measuring the performance of the Group on an underlying
basis. The Board and our managers use these financial measures to
evaluate our operating performance. Non-IFRS financial measures
should not be considered in isolation from, or as a substitute for,
financial information presented in compliance with IFRS. Similarly,
non-IFRS measures as reported by us may not be comparable with
similar measures reported by other companies.
Due to the nature of acquisitions,
costs associated with those acquisitions, subsequent integration
costs and the non-cash element of certain charges, the Directors
believe that adjusted measures provide shareholders with a useful
representation of the underlying earnings derived from the Group's
business and a more comparable view of the year-on-year underlying
financial performance of the Group.
A reconciliation between statutory
operating profit and EBITDA is shown below:
|
|
HY25
|
HY24
|
Continuing operations
|
|
£'m
|
£'m
|
Operating profit/(loss)
|
|
3.4
|
(5.9)
|
Amortisation of acquisition
intangibles
|
|
3.1
|
3.1
|
Depreciation and amortisation of
non-acquisition intangibles
|
|
6.3
|
5.7
|
EBITDA
|
|
12.8
|
2.9
|
A reconciliation between adjusted
and statutory performance measure for the continuing operations is
shown below:
Six months ended 30 September 2024
Continuing operations
|
Profit
before tax
£'m
|
Operating
profit
£'m
|
EBITDA
£'m
|
Statutory reported
|
2.4
|
3.4
|
12.8
|
Restructuring costs
|
2.1
|
2.1
|
2.1
|
Amortisation of acquired
intangibles
|
3.1
|
3.1
|
-
|
Share-based payments (excluding
SAYE schemes)
|
0.4
|
0.4
|
0.4
|
Adjusted reported
|
8.0
|
9.0
|
15.3
|
Six months ended 30 September 2023
Continuing operations
|
(Loss)/profit before
tax
£'m
|
Operating
profit
£'m
|
EBITDA
£'m
|
Statutory reported
|
(8.7)
|
(5.9)
|
2.9
|
Acquisition and disposal costs
(including strategic review costs)
|
4.4
|
4.4
|
4.4
|
Restructuring costs
|
4.1
|
4.1
|
4.1
|
Amortisation of acquired
intangibles
|
3.1
|
3.1
|
-
|
Share-based payments (excluding
SAYE schemes)
|
0.8
|
0.8
|
0.8
|
Fair value losses in contingent
consideration and acquisition related incentive schemes
|
3.2
|
3.2
|
3.2
|
Adjusted reported
|
6.9
|
9.7
|
15.4
|
Adjusting items
There were no acquisition and
disposal costs (including strategic review costs) in the period for
continuing operations as the Group did not undertake any
acquisitions. The prior period costs of £4.4 million were the costs
associated with the Strategic Review and the four bolt-on
acquisitions that took place at the start of HY24.
Restructuring costs, being the
costs associated with the integration of acquisitions, have been a
key component of delivering shareholder value by increasing future
returns made on acquired businesses. Restructuring costs for the
period for continuing operations were £2.1 million (HY24: £4.1
million) reflecting the finalisation of restructuring investment.
In the absence of any future acquisitions, we do not anticipate any
further restructuring costs.
Amortisation of acquired
intangible assets for the period was £3.1 million (HY24: £3.1
million). Non-cash share-based payment charge for the period was
£0.4 million (HY24: £0.8 million) and largely relates to the charge
for executive share-based plans.
Certain long term incentive
schemes for platform businesses have been established to
incentivise key members of our platform acquisition's senior
management to create shareholder value through the successful
acquisition, restructuring and integration of businesses in their
chosen service sectors. These schemes have similar characteristics
to earn out structures in place within the Group and have a similar
purpose. As such, these schemes are considered to be part of the
investing activities of the group and are not-recurring in
nature.
Further details on the items
considered when arriving at adjusted performance measures can be
found in Note 3.
Earnings per share
Basic adjusted earnings per share
are calculated as adjusted profit for the continuing operations for
the year less a standard tax charge divided by the weighted average
number of shares in issue in the year. Basic earnings per share
reflect the actual tax charge.
Earnings per share* (EPS) - Continuing
Operations
|
HY25
|
HY24
|
Basic adjusted earnings per
share
|
6.4p
|
5.4p
|
Basic earnings/(loss) per
share
|
2.5p
|
(9.3)p
|
*Refer to note 5
Weighted average number of shares
in issue was 93,172,661 (HY24: 96,072,077) with the reduction
reflecting the ongoing share buyback programme where the Company
purchased 8,946,087 in the period. Following the cancellation of
the shares repurchased, Marlowe had 88,004,519 ordinary shares of
50 pence each in issue as at 30 September 2024.
Interest
Finance costs for the continuing
operations amounted to £1.0 million in the period (HY24: £2.8
million). This reflects the apportioned interest relating to the
utilisation of the previous debt facility at the start of the
reporting year which has since been retired and interest costs from
lease liabilities.
Taxation
UK Corporation Tax is calculated
at 25% of the estimated assessable profit for the year.
Statement of financial position
The Group maintains a strong
balance sheet with net assets as at 30 September 2024 of £214.6
million (30 September 2023: £438.3 million). At the same date total
assets were £306.9 million (30 September 2023: £893.2 million), and
total liabilities were £92.3 million (30 September 2023: £454.9
million). Total assets primarily consist of intangible assets of
£150.8 million and trade and other receivable of £83.7 million.
Total liabilities include trade payable of £59.7 million and
deferred tax liabilities of £9.7 million which largely relate to
intangible assets.
Cash flow, net debt and financing
The primary net debt movements in
the period reflects the completion of the Divestment and the return
of capital to shareholders.
|
|
|
|
HY25
£m
|
Cash generated from Group operations before interest, tax,
disposal and restructuring costs
|
20.6
|
Disposal costs
|
(10.8)
|
Restructuring costs
|
(3.4)
|
Cash generated from Group operations before interest and
tax
|
6.4
|
Lease repayments
|
(5.8)
|
Net finance costs
|
(3.4)
|
Tax
|
(4.8)
|
Net capex
|
(4.3)
|
Net Divestment proceeds (net of
cash)
|
410.5
|
Proceeds from share
issuance
|
0.3
|
Dividend
|
(150.3)
|
Share repurchases (inc. costs
associated with repurchases)
|
(41.2)
|
-Movement in net debt
|
207.4
|
|
|
Opening net debt (excluding
leases)
|
(176.6)
|
Closing net cash (excluding
leases)
|
30.8
|
|
|
|
|
During the period, Marlowe
generated £20.6 million of cash from operations before
restructuring costs of £3.4 million and disposal costs of £10.8
million which largely relate to the costs of the Divestment and
Demerger in the period.
The Group had £5.8 million of
lease expenses which largely relate to continuing operations. Net
capital expenditure totalled £4.3 million of which £1.8 million
relates to the continuing operations.
In the period the Group repaid its
old debt facility following the proceeds received on the completion
of the Divestment. The Group then returned £150.3 million to
shareholders via a dividend and subsequently £41.0 million via the
share buyback programme[2] in the
period.
Net cash as at 30 September 2024,
including inter alia £21.6 million of lease liabilities, amounted
to £9.2 million (31 March 2024 net debt £203.2 million). Adjusted
net cash (excluding lease liabilities) was £30.8 million (31 March
2024 net debt £176.6 million). Since the period end, the Group has
returned a further £10.0 million to shareholders via the share
buyback programme, as of 4 December 2024.
On 24 June 2024, the Group entered
into a new unsecured 3-year Revolving Credit Facility ("RCF") of
£50 million with an uncommitted accordion facility of £50 million,
these facilities are currently undrawn.
Key Performance Indicators ('KPIs')
The Group uses many different KPIs
at an operational level which are specific to the business and
provide information to management. The Board uses KPIs that focus
on the financial performance of the Group such as revenue, adjusted
EBITDA, adjusted EPS and net cash generated from
operations.
Unaudited consolidated statement
of comprehensive income
For the period ended 30 September
2024
|
|
|
|
|
Unaudited six months ended
30 September 2024
|
Unaudited six months ended
30 September 2023
|
|
Note
|
Continuing
operations
|
Discontinued
operations
|
Total
|
Continuing
Operations
|
Discontinued
operations
|
Total
|
|
|
£'m
|
£'m
|
£'m
|
£'m
|
£'m
|
£'m
|
|
|
|
|
|
|
|
|
Revenue
|
2
|
151.7
|
68.7
|
220.4
|
146.3
|
105.0
|
251.3
|
Cost of sales
|
|
(91.7)
|
(41.6)
|
(133.3)
|
(89.2)
|
(54.4)
|
(143.6)
|
Gross profit
|
|
60.0
|
27.1
|
87.1
|
57.1
|
50.6
|
107.7
|
Administrative expenses excluding
acquisition and other costs
|
|
(51.0)
|
(15.9)
|
(66.9)
|
(47.4)
|
(27.3)
|
(74.7)
|
Acquisition and disposal costs
(including strategic review)
|
3
|
-
|
(10.8)
|
(10.8)
|
(4.4)
|
(1.1)
|
(5.5)
|
Restructuring costs
|
3
|
(2.1)
|
(1.3)
|
(3.4)
|
(4.1)
|
(5.3)
|
(9.4)
|
Amortisation of acquired
intangibles
|
3
|
(3.1)
|
(3.4)
|
(6.5)
|
(3.1)
|
(9.7)
|
(12.8)
|
Share based payments (excluding
SAYE schemes) and legacy long-term incentives
|
3
|
(0.4)
|
-
|
(0.4)
|
(0.8)
|
-
|
(0.8)
|
Fair value losses in contingent
consideration and acquisition related incentive schemes
|
3
|
-
|
-
|
-
|
(3.2)
|
(1.3)
|
(4.5)
|
Total administrative expenses
|
|
(56.6)
|
(31.4)
|
(88.0)
|
(63.0)
|
(44.7)
|
(107.7)
|
Operating profit/(loss)
|
|
3.4
|
(4.3)
|
(0.9)
|
(5.9)
|
5.9
|
-
|
Finance costs
|
|
(1.0)
|
(2.3)
|
(3.3)
|
(2.8)
|
(6.1)
|
(8.9)
|
Profit on disposal of discontinued
operations
|
|
-
|
165.9
|
165.9
|
-
|
-
|
-
|
Profit/(loss) before tax
|
|
2.4
|
159.3
|
161.7
|
(8.7)
|
(0.2)
|
(8.9)
|
Income tax
credit/(charge)
|
4
|
(0.1)
|
0.9
|
0.8
|
(0.2)
|
(0.1)
|
(0.3)
|
Profit/(loss) for the year
|
|
2.3
|
160.2
|
162.5
|
(8.9)
|
(0.3)
|
(9.2)
|
Other comprehensive
income
|
|
|
|
|
|
|
|
Total comprehensive profit /(loss) for the
year
|
|
2.3
|
160.2
|
162.5
|
(8.9)
|
(0.3)
|
(9.2)
|
Attributable to owners of
the parent
|
|
2.3
|
160.2
|
162.5
|
(8.9)
|
(0.3)
|
(9.2)
|
Profit/(loss) per share attributable to owners of the parent
(pence)
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
Basic
|
5
|
2.5p
|
|
174.4p
|
(9.3)p
|
|
(9.6)p
|
Diluted
|
5
|
2.5p
|
|
173.8p
|
(9.3)p
|
|
(9.6)p
|
Unaudited consolidated statement of
comprehensive income
|
|
|
|
|
Audited year ended 31 March
2024
|
|
Note
|
Continuing
operations
|
Discontinued
operations
|
Total
|
|
|
£'m
|
£'m
|
£'m
|
|
|
|
|
|
Revenue
|
2
|
292.3
|
210.9
|
503.2
|
Cost of sales
|
|
(176.9)
|
(108.6)
|
(285.5)
|
Gross profit
|
|
115.4
|
102.3
|
217.7
|
Administrative expenses excluding
acquisition and other costs
|
|
(96.9)
|
(55.4)
|
(152.3)
|
Acquisition and disposal costs
(including strategic review)
|
3
|
(5.1)
|
(2.7)
|
(7.8)
|
Restructuring costs
|
3
|
(8.3)
|
(9.9)
|
(18.2)
|
Amortisation of acquired
intangibles
|
3
|
(6.3)
|
(19.3)
|
(25.6)
|
Share based payments (excluding
SAYE schemes) and legacy long-term incentives
|
3
|
0.8
|
-
|
0.8
|
Fair value losses in contingent
consideration and acquisition related incentive schemes
|
3
|
(2.8)
|
(2.2)
|
(5.0)
|
Total administrative expenses
|
|
(118.6)
|
(89.5)
|
(208.1)
|
Operating profit/(loss)
|
|
(3.2)
|
12.8
|
9.6
|
Finance costs
|
|
(5.9)
|
(12.7)
|
(18.6)
|
Exceptional finance
costs
|
|
(0.1)
|
(1.8)
|
(1.9)
|
Total finance costs
|
|
(6.0)
|
(14.5)
|
(20.5)
|
Loss before tax
|
|
(9.2)
|
(1.7)
|
(10.9)
|
Income tax
credit/(charge)
|
4
|
3.4
|
(2.7)
|
0.7
|
Loss for the year
|
|
(5.8)
|
(4.4)
|
(10.2)
|
Other comprehensive
income
|
|
-
|
-
|
-
|
Total comprehensive loss for the year
|
|
(5.8)
|
(4.4)
|
(10.2)
|
Attributable to owners of
the parent
|
|
(5.8)
|
(4.4)
|
(10.2)
|
Loss per share attributable to owners of the parent
(pence)
|
|
|
|
|
Total
|
|
|
|
|
Basic
|
5
|
(6.0)p
|
|
(10.6)p
|
Diluted
|
5
|
(6.0)p
|
|
(10.6)p
|
|
|
|
|
|
|
|
Unaudited consolidated statement
of changes in equity
For the six months ended 30
September 2024
|
Share
capital
£m
|
Share
premium
£m
|
Merger
reserve
£m
|
Capital Redemption
reserve
£m
|
Other
reserves
£m
|
Retained earnings/(deficit)
£m
|
Total
equity
£m
|
|
|
|
|
|
|
|
|
|
|
Balance at 1 April 2023
|
47.9
|
384.8
|
9.9
|
-
|
4.6
|
(3.9)
|
443.3
|
|
Loss for the period
|
-
|
-
|
-
|
-
|
-
|
(9.2)
|
(9.2)
|
|
Total comprehensive loss for the period
|
-
|
-
|
-
|
-
|
-
|
(9.2)
|
(9.2)
|
|
|
|
|
|
|
|
|
|
|
Transaction with owners
|
|
|
|
|
|
|
|
|
Share-based payments
|
-
|
-
|
-
|
-
|
1.2
|
-
|
1.2
|
|
Issue of shares during the
year
|
0.3
|
0.1
|
2.6
|
-
|
-
|
-
|
3.0
|
|
Cancellation of share
premium
|
-
|
(384.9)
|
-
|
-
|
-
|
384.9
|
-
|
|
|
0.3
|
(384.8)
|
2.6
|
-
|
1.2
|
384.9
|
4.2
|
|
|
|
|
|
|
|
|
|
|
Balance at 30 September 2023 (unaudited)
|
48.2
|
-
|
12.5
|
-
|
5.8
|
371.8
|
438.3
|
|
|
|
|
|
|
|
|
|
|
Balance at 1 October
2023
|
48.2
|
-
|
12.5
|
-
|
5.8
|
371.8
|
438.3
|
|
Loss for the period
|
|
|
|
|
|
(1.0)
|
(1.0)
|
|
Total comprehensive loss for the period
|
-
|
-
|
-
|
-
|
-
|
(1.0)
|
(1.0)
|
|
|
|
|
|
|
|
|
|
|
Transaction with owners
|
|
|
|
|
|
|
|
|
Share-based payments
|
-
|
-
|
-
|
-
|
(1.3)
|
-
|
(1.3)
|
|
Issue of shares during the
year
|
0.2
|
1.3
|
-
|
-
|
-
|
-
|
1.5
|
|
|
0.2
|
1.3
|
-
|
-
|
(1.3)
|
-
|
0.2
|
|
|
|
|
|
|
|
|
|
|
Balance at 31 March 2024
|
48.4
|
1.3
|
12.5
|
-
|
4.5
|
370.8
|
437.5
|
|
|
|
|
|
|
|
|
|
|
Balance at 1 April 2024
|
48.4
|
1.3
|
12.5
|
-
|
4.5
|
370.8
|
437.5
|
|
Profit for the period
|
-
|
-
|
-
|
-
|
-
|
162.5
|
162.5
|
|
Total comprehensive profit for the period
|
-
|
-
|
-
|
-
|
-
|
162.5
|
162.5
|
|
|
|
|
|
|
|
|
|
|
Transaction with owners
|
|
|
|
|
|
|
|
|
Share-based payments
|
-
|
-
|
-
|
-
|
0.7
|
-
|
0.7
|
|
Issue of shares during the
period
|
0.1
|
0.2
|
-
|
-
|
-
|
-
|
0.3
|
|
Purchase and cancellation of own
shares
|
(4.5)
|
(0.2)
|
-
|
4.5
|
-
|
(41.2)
|
(41.4)
|
|
Cash dividend paid to
shareholders
|
-
|
-
|
-
|
-
|
-
|
(150.3)
|
(150.3)
|
|
Distribution of discontinued
operations
|
-
|
-
|
-
|
-
|
-
|
(194.7)
|
(194.7)
|
|
|
(4.4)
|
-
|
-
|
4.5
|
0.7
|
(386.2)
|
(385.5)
|
|
|
|
|
|
|
|
|
|
|
Balance at 30 September 2024 (unaudited)
|
44.0
|
1.3
|
12.5
|
4.5
|
5.2
|
147.1
|
214.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unaudited consolidated statement
of financial position
As at 30 September 2024
|
Notes
|
Unaudited
six months
ended 30 September
2024
£'m
|
Unaudited
six months
ended 30 September
2023
£'m
|
Audited
year
ended
31 March
2024
£'m
|
ASSETS
|
|
|
|
|
Non-current assets
|
|
|
|
|
Intangible assets
|
7
|
150.8
|
667.4
|
343.2
|
Property, plant and
equipment
|
|
8.0
|
13.1
|
10.1
|
Right of use assets
|
|
19.9
|
25.7
|
25.4
|
Trade and other
receivables
|
|
-
|
2.1
|
-
|
Deferred tax asset
|
|
4.4
|
4.4
|
4.4
|
Total non-current assets
|
|
183.1
|
712.7
|
383.1
|
|
|
|
|
|
Current assets
|
|
|
|
|
Inventories
|
|
9.1
|
9.9
|
9.7
|
Trade and other
receivables
|
8
|
83.7
|
132.0
|
98.0
|
Cash and cash
equivalents
|
9
|
30.8
|
36.3
|
-
|
Current tax asset
|
|
0.2
|
2.3
|
1.3
|
Assets classified as held for
sale
|
|
-
|
-
|
398.2
|
Total current assets
|
|
123.8
|
180.5
|
507.2
|
|
|
|
|
|
Total assets
|
|
306.9
|
893.2
|
890.3
|
|
|
|
|
|
LIABILITIES
|
|
|
|
|
Current liabilities
|
|
|
|
|
Trade and other payables
|
|
(59.7)
|
(129.4)
|
(83.5)
|
Financial liabilities - bank
overdrafts
|
9
|
-
|
-
|
(25.8)
|
Financial liabilities -
borrowings
|
9
|
-
|
-
|
(206.0)
|
Financial liabilities - lease
liabilities
|
9
|
(12.5)
|
(9.4)
|
(9.4)
|
Provisions
|
|
(1.1)
|
(1.6)
|
(1.2)
|
Liabilities directly associated
with assets classified as held for sale
|
|
-
|
-
|
(82.3)
|
|
|
(73.3)
|
(140.4)
|
(408.2)
|
Non-current liabilities
|
|
|
|
|
Trade and other payables
|
|
-
|
(12.2)
|
(0.7)
|
Financial liabilities -
borrowings
|
9
|
-
|
(229.0)
|
-
|
Financial liabilities - lease
liabilities
|
9
|
(9.1)
|
(17.3)
|
(16.9)
|
Deferred tax liabilities
|
|
(9.7)
|
(54.7)
|
(26.0)
|
Provisions
|
|
(0.2)
|
(1.3)
|
(1.0)
|
|
|
(19.0)
|
(314.5)
|
(44.6)
|
|
|
|
|
|
Total liabilities
|
|
(92.3)
|
(454.9)
|
(452.8)
|
|
|
|
|
|
Net assets
|
|
214.6
|
438.3
|
437.5
|
Unaudited consolidated statement
of financial position
As at 30 September 2024
|
Notes
|
Unaudited
six months
ended 30 September
2024
£'m
|
Unaudited
six months
ended 30 September
2023
£'m
|
Audited
year
ended
31 March
2024
£'m
|
EQUITY
|
|
|
|
|
Share capital
|
|
44.0
|
48.2
|
48.4
|
Share premium account
|
|
1.3
|
-
|
1.3
|
Merger relief reserve
|
|
12.5
|
12.5
|
12.5
|
Capital Redemption
Reserve
|
|
4.5
|
-
|
-
|
Other reserves
|
|
5.2
|
5.8
|
4.5
|
Retained earnings
|
|
147.1
|
371.8
|
370.8
|
Equity attributable to owners of
parent
|
|
214.6
|
438.3
|
437.5
|
Unaudited consolidated statement
of cash flows
For the six months ended 30
September 2024
|
Notes
|
Unaudited
six months
ended 30 September
2024
£'m
|
Unaudited
six months
ended 30 September
2023
£'m
|
Audited
year
ended
31 March
2024
£'m
|
Net cash generated from operating activities before interest
and tax
|
11
|
6.4
|
16.7
|
57.8
|
Net finance costs
|
|
(3.4)
|
(8.3)
|
(17.8)
|
Income taxes paid
|
|
(4.8)
|
(1.0)
|
(2.0)
|
Net cash (used in)/generated from operating
activities
|
|
(1.8)
|
7.4
|
38.0
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
Purchases of property, plant and
equipment and non-acquisition intangibles
|
|
(5.0)
|
(7.3)
|
(14.4)
|
Disposal of property, plant and
equipment
|
|
0.7
|
0.4
|
1.4
|
Consideration received
|
|
-
|
-
|
4.3
|
Purchase of subsidiary undertakings
net of cash acquired
|
|
-
|
(26.3)
|
(31.7)
|
Disposal of discontinued
operations
|
|
465.7
|
-
|
-
|
Cash flows generated/(used in) investing
activities
|
|
461.4
|
(33.2)
|
(40.4)
|
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
|
Proceeds from share
issues
|
|
0.3
|
-
|
1.5
|
Utilisation of debt
facility
|
|
3.0
|
42.0
|
51.3
|
Repayment of debt
facility
|
|
(209.0)
|
(4.0)
|
(36.3)
|
Settlement of contingent
consideration
|
|
-
|
-
|
(2.5)
|
Repayment of debt upon purchase of
subsidiary undertaking
|
|
-
|
(0.4)
|
(0.5)
|
Lease repayments
|
|
(5.8)
|
(5.7)
|
(11.9)
|
Dividend
|
|
(150.3)
|
-
|
-
|
Share buybacks
|
|
(41.2)
|
-
|
-
|
Net cash (used in)/generated from financing
activities
|
|
(403.0)
|
31.9
|
1.6
|
|
|
|
|
|
Net increase/(decrease) in cash and
cash equivalents
|
|
56.6
|
6.1
|
(0.8)
|
Cash and cash equivalents at start
of period
|
|
(25.8)
|
30.2
|
30.2
|
Cash and cash equivalents from
discontinued operations
|
|
-
|
-
|
(55.2)
|
Cash and cash equivalents at the end of
period
|
|
30.8
|
36.3
|
(25.8)
|
|
|
|
|
|
Cash and cash equivalents shown above
comprise:
|
|
|
|
|
Cash at bank
|
|
30.8
|
36.3
|
-
|
Bank overdrafts
|
|
-
|
-
|
(25.8)
|
Notes to the financial information for the year ended 30
September 2024
1. Basis of Preparation
Basis of preparation
The unaudited consolidated interim
financial information of the Group for the six months ended 30
September 2024 was approved by the Board of Directors and
authorised for issue on 4 December 2024. The disclosed figures are
not statutory accounts in terms of Section 434 of the Companies Act
2006. Statutory accounts for the year ended 31 March 2024, on which
the auditors gave an audit report which was unqualified and did not
contain a statement under section 498(2) or (3) of the Companies
Act 2006, have been filed with the Registrar of Companies. The
annual financial statements of the Group are prepared in accordance
with applicable law and UK-adopted International Accounting
Standards (UK-IAS).
The comparative figures for the
financial year ended 31 March 2024 and the six months ended 30
September 2023 are consistent with the Group's annual financial
statements and interim financial statements
respectively.
The consolidated interim financial
results are presented in pounds sterling and, unless stated
otherwise, shown in pounds million to one decimal place.
Going concern
The Group's business activities,
together with the factors likely to affect its future development,
performance, financial position, its cash flows, liquidity
position, principal risks and uncertainties affecting the business
are set out in the Business Review.
The Group meets its day-to-day
working capital requirements through cash generation and its
financing facilities.
On 24 June 2024, a new financing
facility was put in place allowing the Group to draw up to a
maximum of £100 million subject to certain covenants. To date there
have been no drawdowns against the facility. Given that the
underlying business is cash generating and having considered FY25
budgets and FY26 forecasts, the Directors are comfortable that the
Group has adequate resources to meet its ongoing financing
requirements.
Details of the Group's borrowing
facilities are given in note 9. The Group's budget for 2025 and
forecasts for 2026, show that the Group should be able to operate
within the level of its new facility and comply with the relevant
covenants.
The Directors have a reasonable
expectation that the Group has adequate resources to continue in
operational existence for a period of at least 12 months from the
approval date of this report and accordingly they continue to adopt
the going concern basis of accounting in preparing the annual
financial statements. In making this assessment, the Directors have
considered the financing arrangements available to the Group and
the Group's cashflow forecasts, taking into account significant but
plausible downside trading scenarios.
Accounting policies
This interim report has been
prepared in accordance with the recognition and measurement
requirements of UK adopted International Accounting Standards (IAS)
but does not include all the disclosures that would be required
under IAS. The accounting policies adopted in the interim financial
statements are consistent with those adopted in the last annual
report for financial year ended 31 March 2024 and those applicable
for the year ending 31 March 2025.
Critical accounting estimates and
judgements continue to be applied to the identification of
separable intangibles on acquisition and rate of customer
attrition, acquisition and other costs, valuation of separable
intangibles on acquisition, impairment of non-financial assets,
impairment of trade receivables and recoverability of amounts due
from contract assets.
2. Segmental analysis
The Group has been organised into
one main reporting segment, Testing, Inspection & Certification
("TIC"). At each reporting date, the Group reviews its
reporting segments to determine if the segment disclosure continues
to be appropriate.
As described in the business
review, the Board announced in February 2024 that it had entered
into a binding agreement for the sale of certain of the GRC
software and services assets. This included all assets from the
Worknest, Health and Safety compliance and Elogbooks operating
segments. The disposal completed on 31 May 2024 and the
disposal group assets were classified as held for sale at 31 March
2024 and trading results classified as discontinued
operations.
Additionally, and as described in
the business review, the Board announced in September 2024 the
demerger of its Occupational Health divisions from Marlowe to form
Optima Health plc as an independent company. The demerger completed
on the 26 September 2024 and the demerged group assets and trading
results were classified as discontinued operations.
During the year, there has not
been a significant change to the underlying nature of the retained
business. However, the disposal and demerger noted above has
resulted in a change to the reportable segments with TIC being the
only operating segment continuing. Other than this, the results and
economic characteristics of the business remains consistent with
the prior year and therefore continuing to disclose the reportable
segment consistently is appropriate for six-month period ending 30
September
2024.
Services per segment operate as
described in the Business Review and the judgments taken in
aggregating the operating segment are disclosed in note 2. The key
profit measures are revenue, adjusted EBITDA and adjusted profit
before tax and are shown before acquisition and disposal costs
(including strategic review costs), amortisation of acquired
intangibles, share based payments (excluding SAYE schemes) and fair
value gains/losses in contingent
consideration.
The vast majority of trading of
the Group is undertaken within the United Kingdom. Segment assets
include intangibles, property, plant and equipment, inventories,
receivables and cash. Central assets include deferred tax and head
office assets. Segment liabilities comprise operating liabilities.
Central liabilities include deferred tax, corporate borrowings and
head office liabilities. Capital expenditure comprises additions to
application software, property, plant and equipment. Segment assets
and liabilities are allocated between segments on an actual
basis.
Unaudited continuing operations for six-month period
ended
|
30 September
2024
|
30 September
2023
|
|
TIC
|
Head
Office
|
Total
|
TIC
|
Head
Office
|
Total
|
Continuing operations
|
£'m
|
£'m
|
£'m
|
£'m
|
£'m
|
£'m
|
Revenue
|
158.0
|
-
|
158.0
|
150.6
|
-
|
150.6
|
Inter-segment
elimination
|
(6.3)
|
-
|
(6.3)
|
(4.3)
|
-
|
(4.3)
|
Revenue from external
customers
|
151.7
|
-
|
151.7
|
146.3
|
-
|
146.3
|
Segment adjusted operating
profit/(loss)
|
11.8
|
(2.8)
|
9.0
|
12.3
|
(2.6)
|
9.7
|
Acquisition and disposal costs
(including strategic review costs)
|
|
|
-
|
|
|
(4.4)
|
Restructuring costs
|
|
|
(2.1)
|
|
|
(4.1)
|
Amortisation of acquired
intangibles
|
|
|
(3.1)
|
|
|
(3.1)
|
Share based payments (excluding
SAYE schemes) and legacy long-term incentives
|
|
|
(0.4)
|
|
|
(0.8)
|
Fair value losses n contingent
consideration and acquisition related incentive schemes
|
|
|
-
|
|
|
(3.2)
|
Operating profit/(loss)
|
|
|
3.4
|
|
|
(5.9)
|
Finance costs
|
|
|
(1.0)
|
|
|
(2.8)
|
Profit/(loss) before
tax
|
|
|
2.4
|
|
|
(8.7)
|
Tax charge
|
|
|
(0.1)
|
|
|
(0.2)
|
Profit/(loss) after tax
|
|
|
2.3
|
|
|
(8.9)
|
|
|
|
|
|
|
|
Segment assets
|
276.9
|
30.0
|
306.9
|
275.2
|
480.0
|
755.2
|
Segment liabilities
|
(91.6)
|
(0.7)
|
(92.3)
|
(75.6)
|
(271.7)
|
(347.3)
|
Capital expenditure
|
(1.8)
|
-
|
(1.8)
|
(1.9)
|
-
|
(1.9)
|
Depreciation and
amortisation
|
(6.3)
|
(3.1)
|
(9.4)
|
(5.7)
|
(3.4)
|
(9.1)
|
Audited continuing operations year ended 31 March
2024
|
31 March
2024
|
|
TIC
|
Head
Office
|
Total
|
|
Continuing operations
|
£'m
|
£'m
|
£'m
|
|
Revenue
|
303.7
|
-
|
303.7
|
|
Inter-segment
elimination
|
(11.4)
|
-
|
(11.4)
|
|
Revenue from external
customers
|
292.3
|
-
|
292.3
|
|
Segment adjusted operating
profit/(loss)
|
23.2
|
(4.7)
|
18.5
|
|
Acquisition and disposal costs
(including strategic review costs)
|
|
|
(5.1)
|
|
Restructuring costs
|
|
|
(8.3)
|
|
Amortisation of acquired
intangibles
|
|
|
(6.3)
|
|
Share based payments (excluding
SAYE schemes) and legacy long-term incentives
|
|
|
0.8
|
|
Fair value losses in contingent
consideration and acquisition related incentive schemes
|
|
|
(2.8)
|
|
Operating loss
|
|
|
(3.2)
|
|
Finance costs
|
|
|
(5.9)
|
|
Exceptional finance
costs
|
|
|
(0.1)
|
|
Loss before tax
|
|
|
(9.2)
|
|
Tax credit
|
|
|
3.4
|
|
Loss after tax
|
|
|
(5.8)
|
|
|
|
|
|
|
Segment assets
|
89.3
|
379.4
|
468.7
|
|
Segment liabilities
|
(79.6)
|
(266.1)
|
(345.7)
|
|
Capital expenditure
|
(3.8)
|
-
|
(3.8)
|
|
Depreciation and
amortisation
|
(12.0)
|
(6.6)
|
(18.6)
|
|
|
|
|
|
|
|
Discontinued operations
|
|
|
|
Unaudited
six months
ended 30 September
2024
|
Unaudited
six months
ended 30 September
2023
|
Audited
year
ended
31 March
2024
|
Discontinued operations
|
£'m
|
£'m
|
£'m
|
Revenue
|
69.5
|
106.5
|
214.9
|
Inter-segment
elimination
|
(0.8)
|
(1.5)
|
(4.0)
|
Revenue from external
customers
|
68.7
|
105.0
|
210.9
|
Segment adjusted operating
profit
|
11.2
|
23.3
|
46.9
|
Acquisition and disposal costs
(including strategic review costs)
|
(10.8)
|
(1.1)
|
(2.7)
|
Restructuring costs
|
(1.3)
|
(5.3)
|
(9.9)
|
Amortisation of acquired
intangibles
|
(3.4)
|
(9.7)
|
(19.3)
|
Fair value losses in contingent
consideration and acquisition related incentive schemes
|
-
|
(1.3)
|
(2.2)
|
Operating (loss)/profit
|
(4.3)
|
5.9
|
12.8
|
Finance costs
|
(2.3)
|
(6.1)
|
(12.7)
|
Exceptional finance
costs
|
-
|
-
|
(1.8)
|
Profit on disposal of discontinued
operations
|
165.9
|
-
|
-
|
Profit/(loss) before
tax
|
159.3
|
(0.2)
|
(1.7)
|
Tax credit/(charge)
|
0.9
|
(0.1)
|
(2.7)
|
Profit/(loss) after tax
|
160.2
|
(0.3)
|
(4.4)
|
|
|
|
|
Segment assets
|
-
|
138.0
|
421.6
|
Segment liabilities
|
-
|
(107.6)
|
(107.1)
|
Capital expenditure
|
(3.2)
|
(5.4)
|
(10.7)
|
Depreciation and
amortisation
|
(6.2)
|
(13.7)
|
(27.9)
|
|
|
|
|
|
|
The revenue from external
customers was derived from the Group's principal activities
primarily in the UK (where the Company is domiciled).
Reconciliation of segment adjusted operating profit to
adjusted EBITDA
Unaudited continuing operations for six-month period
ended
|
30 September
2024
|
30 September
2023
|
|
TIC
|
Head
Office
|
Total
|
TIC
|
Head
Office
|
Total
|
Continuing operations
|
£'m
|
£'m
|
£'m
|
£'m
|
£'m
|
£'m
|
Segment adjusted operating
profit/(loss)
|
11.8
|
(2.8)
|
9.0
|
12.3
|
(2.6)
|
9.7
|
Depreciation and amortisation of
non-acquisition intangibles
|
6.2
|
0.1
|
6.3
|
5.7
|
-
|
5.7
|
Adjusted EBITDA
|
18.0
|
(2.7)
|
15.3
|
18.0
|
(2.6)
|
15.4
|
Audited continuing operations year ended 31 March
2024
|
31 March
2024
|
|
TIC
|
Head
Office
|
Total
|
Continuing operations
|
£'m
|
£'m
|
£'m
|
Segment adjusted operating
profit/(loss)
|
23.2
|
(4.7)
|
18.5
|
Depreciation and amortisation of
non-acquisition intangibles
|
12.0
|
0.4
|
12.4
|
Adjusted EBITDA
|
35.2
|
(4.3)
|
30.9
|
Discontinued operations
|
|
|
|
Unaudited
six months
ended 30 September
2024
|
Unaudited
six months
ended 30 September
2023
|
Audited
year
ended
31 March
2024
|
Discontinued operations
|
£'m
|
£'m
|
£'m
|
Segment adjusted operating
profit
|
11.2
|
23.3
|
46.9
|
Depreciation and amortisation of
non-acquisition intangibles
|
2.7
|
4.2
|
8.5
|
Adjusted EBITDA
|
13.9
|
27.5
|
55.4
|
|
|
|
|
|
|
The above tables reconcile segment
adjusted operating profit/(loss) to adjusted EBITDA, which excludes
separately disclosed acquisition and other costs, to the standard
profit measure under IFRS (Operating Profit). This is the Group's
Alternative Profit Measure used when discussing the performance of
the Group. The Directors believe that adjusted EBITDA and operating
profit is the most appropriate approach for ascertaining the
underlying trading performance and trends as it reflects the
measures used internally by senior management for all discussions
of performance and also reflects the starting profit measure when
calculating the Group's banking covenants.
Adjusted EBITDA is not defined by
IFRS and therefore may not be directly comparable with other
companies' adjusted profit measures. It is not intended to be a
substitute, or superior to, IFRS measurements of profit.
Major
customers
For the six month period ended 30
September 2024, no customers (30 September 2023: nil) individually
accounted for more than 10% of the Group's total
revenue.
3. Adjusting items
Due to the nature of acquisition
and other costs in relation to each acquisition and the non-cash
element of certain charges, the Directors believe that adjusted
operating profit, adjusted EBITDA and adjusted measures of profit
before tax and earnings per share provide shareholders with a more
appropriate representation of the underlying earnings derived from
the Group's business and a more comparable view of the year-on-year
underlying financial performance of the Group. The adjusting items
shown on the consolidated statement of comprehensive income and the
rationale behind the Director's view that these should be included
as adjusting items are detailed below:
Adjusting item
|
Rationale
|
Acquisition and disposal costs
(including strategic review costs)
|
Acquisition and disposal costs
(including strategic review costs) totalled £10.8 million during
the period (HY24: £5.5 million). These costs included the disposal
of certain GRC software and service assets, as well as expenses
associated with the demerger of the Group's Occupational Health
assets, completed in the first half of the year. The strategic
review, conducted in the prior period (HY24), resulted in costs
such as professional fees, legal fees, and staff-related expenses.
These costs are non-recurring and not considered to be reflective
of the underlying trading performance.
|
Restructuring costs
|
Restructuring costs, being the
costs associated with the integration of acquisitions, remain a key
component of delivering shareholder value by increasing returns
made on acquired businesses. Restructuring costs for the six-month
period ending 30 September 2024 were £3.4 million (HY24: £9.4
million) reflecting the integration programmes within period. No
further restructuring expenses are anticipated in the second half
of the year.
Restructuring costs primarily
consisted of:
· The
cost of duplicated staff roles and other duplicated operational
costs during the integration and restructuring period;
· The
redundancy cost of implementing the post completion staff
structures; and
· IT
costs associated with the integration and transfer to Group IT
systems, including costs of third party software used in the
delivery of customer contracts where there is a programme to
transition such software to one of the Group's existing
platforms.
|
Amortisation of acquired
intangibles
|
The amortisation charge is
primarily in relation to acquired intangible assets resulting from
fair value adjustments under IFRS 3. Given the overall size of the
amortisation charge and it being non-cash in nature, this cost is
adjusted for in deriving the Group's alternative performance
measures. In accordance with IFRS 5, no amortisation was recorded
for the GRC software and service assets during the period, as these
assets were classified as held for sale. For transparency, we note
that the Group does not similarly adjust for the related revenue
and results generated from its business combinations in its
alternative profit measures.
|
Share-based payments (excluding
SAYE schemes) and legacy long-term incentives
|
Charges associated with
share-based payment schemes (excluding SAYE schemes which remain
are classed as administrative expenses) and legacy long-term
incentives have been included as adjusting items. Although
share-based compensation is an important aspect of the compensation
of our employees and executives, management believes it is useful
to exclude share-based compensation expenses from adjusted profit
measures to better understand the long-term performance of our
underlying business. Share-based compensation expenses are non-cash
charges and are determined using several factors, including
expectations surrounding future performance, employee forfeiture
rates and, for employee payroll-related tax items, the share price.
As a result, these charges are not reflective of the value
ultimately received from the awards.
|
Fair value losses in contingent
consideration and acquisition related incentive schemes
|
Movements in contingent
consideration are considered to be part of the investing activities
of the Group and are therefore not considered to be reflective of
the underlying trading performance. Further, share based
compensation expenses are not reflective of the value ultimately
received by the recipients of the awards. In addition, certain
legacy long terms incentives are considered to be part of the
investing activities of the Group and non-recurring in
nature.
|
Exceptional finance
costs
|
Exceptional finance costs relate
to the non-cash unwinding of the discount applied to contingent
consideration to reflect the time value of money. Therefore, it is
not considered part of the underlying trading of the
Group.
|
4. Taxation
The underlying tax charge is based
on the expected tax rate (25%) for the year ending 31 March 2025
applied to taxable trading profits for the period. The tax rate
applied to the comparative periods ending 30 September 2023 and 31
March 2024 was 25%.
5. Earnings per ordinary share
Both the basic and diluted
earnings per share have been calculated using the profit
attributable to shareholders of the parent company (Marlowe plc) as
the numerator, i.e. no adjustments to profit were necessary in 2024
or 2023.
|
Unaudited
six months
ended 30
September
2024
|
Unaudited
six months
ended 30
September
2023
|
Audited year
ended
31 March
2024
|
Group
|
|
|
|
Profit/(loss) after tax for the
period
|
£162.5m
|
£(9.2)m
|
£(10.2)m
|
Basic earnings/(loss) per
share
|
174.4p
|
(9.6)p
|
(10.6)p
|
Fully diluted earnings/(loss) per
share
|
173.8p
|
(9.6)p
|
(10.6)p
|
Continuing
|
|
|
|
Profit/(loss) after tax for the
period
|
£2.3m
|
£(8.9)m
|
£(5.8)m
|
Basic earnings/(loss) per
share
|
2.5p
|
(9.3)p
|
(6.0)p
|
Fully diluted earnings/(loss) per
share
|
2.5p
|
(9.3)p
|
(6.0)p
|
|
|
|
|
Weighted average number of shares
in issue
|
93,172,661
|
96,072,077
|
96,418,045
|
Potential dilution of share
options
|
299,833
|
-
|
-
|
Weighted average fully diluted
number of shares in issue
|
93,472,494
|
96,072,077
|
96,418,045
|
Potential dilution of share
options (31 March 2024: 579,564, 30 September 2023: 1,111,486) were
excluded from the diluted weighted-average number of ordinary
shares calculation for the continuing operations because their
effect would have been anti-dilutive.
Adjusted earnings per share
The Directors believe that the
adjusted earnings per share provide a more appropriate
representation of the underlying earnings derived from the Group's
business. The adjusting items are shown in the table
below:
Group
|
Unaudited
six months
ended 30
September
2024
|
Unaudited
six months
ended 30
September
2023
|
Audited
year
ended
31 March
2024
|
Profit/(loss) before tax for the
period
|
161.7
|
(8.9)
|
(10.9)
|
Adjustments:
|
|
|
|
Acquisition and disposal costs
(including strategic review costs)
|
10.8
|
5.5
|
7.8
|
Restructuring costs
|
3.4
|
9.4
|
18.2
|
Amortisation of acquired
intangibles
|
6.5
|
12.8
|
25.6
|
Share-based payments (excluding
SAYE schemes)
|
0.4
|
0.8
|
(0.8)
|
Fair value losses in contingent
consideration and acquisition related incentive schemes
|
-
|
4.5
|
5.0
|
Exceptional finance
costs
|
-
|
-
|
1.9
|
Divestment of discontinued
operations
|
(165.9)
|
-
|
-
|
Adjusted profit before tax for the period
|
16.9
|
24.1
|
46.8
|
Continuing operations
|
Unaudited
six months
ended 30
September
2024
|
Unaudited
six months
ended 30
September
2023
|
Unaudited
year
ended
31 March
2024
|
Profit/(loss) before tax for the
period
|
2.4
|
(8.7)
|
(9.2)
|
Adjustments:
|
|
|
|
Acquisition and disposal costs
(including strategic review costs)
|
-
|
4.4
|
5.1
|
Restructuring costs
|
2.1
|
4.1
|
8.3
|
Amortisation of acquired
intangibles
|
3.1
|
3.1
|
6.3
|
Share-based payments (excluding
SAYE schemes)
|
0.4
|
0.8
|
(0.8)
|
Fair value losses in contingent
consideration and acquisition related incentive schemes
|
-
|
3.2
|
2.8
|
Exceptional finance
costs
|
-
|
-
|
0.1
|
Adjusted profit before tax for the period
|
8.0
|
6.9
|
12.6
|
The adjusted earnings per share,
based on weighted average number of shares in issue during the
year, is calculated below:
Group
|
Unaudited
six months
ended 30
September
2024
|
Unaudited
six months
ended 30
September
2023
|
Audited
year
ended
31 March
2024
|
Adjusted profit before tax
(£'m)
|
16.9
|
24.1
|
46.8
|
Tax at 25%
|
(4.2)
|
(6.0)
|
(11.7)
|
Adjusted profit after taxation
(£'m)
|
12.7
|
18.1
|
35.1
|
Adjusted basic earnings per share
(pence)
|
13.6
|
18.8
|
36.4
|
Adjusted fully diluted earnings per
share (pence)
|
13.6
|
18.8
|
36.4
|
Continuing operations
|
Unaudited
six months
ended 30
September
2024
|
Unaudited
six months
ended 30
September
2023
|
Unaudited
year
ended
31 March
2024
|
Adjusted profit before tax
(£'m)
|
8.0
|
6.9
|
12.6
|
Tax at 25%
|
(2.0)
|
(1.7)
|
(3.1)
|
Adjusted profit after taxation
(£'m)
|
6.0
|
5.2
|
9.5
|
Adjusted basic earnings per share
(pence)
|
6.4
|
5.4
|
9.9
|
Adjusted fully diluted earnings per
share (pence)
|
6.4
|
5.4
|
9.9
|
6. Dividends
On 3rd June 2024, the Company
declared a special dividend in respect of the current year. The
dividend of £1.55 per Marlowe ordinary share amounted to £150.3
million and was paid on 5 July 2024.
In September 2024, Marlowe Plc
declared a non-cash dividend in the form of all of the shares held
in its subsidiary, Optima Health PLC, to its shareholders. The
dividend was measured at the carrying value of the subsidiary
(£194.7m).
7. Intangible assets
|
Goodwill
|
Customer
relationships
|
Applications software
|
Content
database
|
Trade
name
|
Total
|
|
£'m
|
£'m
|
£'m
|
£'m
|
£'m
|
£'m
|
Cost
|
|
|
|
|
|
|
1 April 2023
|
424.7
|
204.7
|
57.9
|
8.0
|
6.1
|
701.4
|
Acquired with subsidiary
|
18.5
|
14.5
|
-
|
0.3
|
-
|
33.3
|
Additions
|
-
|
-
|
5.0
|
-
|
-
|
5.0
|
Disposals
|
-
|
-
|
(0.3)
|
-
|
-
|
(0.3)
|
30 September 2023
|
443.2
|
219.2
|
62.6
|
8.3
|
6.1
|
739.4
|
|
|
|
|
|
|
|
1 October 2023
|
443.2
|
219.2
|
62.6
|
8.3
|
6.1
|
739.4
|
Acquired with subsidiary
|
3.8
|
(3.7)
|
-
|
(0.3)
|
0.8
|
0.6
|
Additions
|
-
|
-
|
5.7
|
-
|
-
|
5.7
|
Disposals
|
-
|
-
|
(0.3)
|
-
|
-
|
(0.3)
|
Reclassified as held for
sale
|
(210.5)
|
(98.5)
|
(33.9)
|
(8.0)
|
(1.8)
|
(352.7)
|
31 March 2024
|
236.5
|
117.0
|
34.1
|
-
|
5.1
|
392.7
|
|
|
|
|
|
|
|
1 April 2024
|
236.5
|
117.0
|
34.1
|
-
|
5.1
|
392.7
|
Acquired with subsidiary
|
-
|
-
|
-
|
-
|
-
|
-
|
Additions
|
-
|
-
|
0.6
|
-
|
-
|
0.6
|
Disposals
|
(118.8)
|
(60.3)
|
(30.9)
|
-
|
(5.1)
|
(215.0)
|
30 September 2024
|
117.7
|
56.7
|
3.8
|
-
|
-
|
178.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated amortisation and
impairment
|
|
|
|
|
|
1 April 2023
|
-
|
42.4
|
12.2
|
1.9
|
0.8
|
57.3
|
Charge for the period
|
-
|
9.7
|
4.2
|
0.7
|
0.3
|
14.9
|
Disposals
|
-
|
-
|
(0.2)
|
-
|
-
|
(0.2)
|
30 September 2023
|
-
|
52.1
|
16.2
|
2.6
|
1.1
|
72.0
|
|
|
|
|
|
|
|
1 October 2023
|
-
|
52.1
|
16.2
|
2.6
|
1.1
|
72.0
|
Charge for the period
|
-
|
9.9
|
4.5
|
0.6
|
0.4
|
15.4
|
Disposals
|
-
|
-
|
(0.4)
|
-
|
-
|
(0.4)
|
Reclassified as held for
sale
|
-
|
(27.2)
|
(6.6)
|
(3.2)
|
(0.4)
|
(37.4)
|
31 March 2024
|
-
|
34.8
|
13.6
|
-
|
1.1
|
49.5
|
|
|
|
|
|
|
|
1 April 2024
|
-
|
34.8
|
13.6
|
-
|
1.1
|
49.5
|
Charge for the period
|
-
|
5.4
|
1.9
|
-
|
0.3
|
7.6
|
Disposals
|
-
|
(13.7)
|
(14.6)
|
-
|
(1.4)
|
(29.7)
|
30 September 2024
|
-
|
26.5
|
0.9
|
-
|
-
|
27.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying amount
|
|
|
|
|
|
|
30 September 2023
|
443.2
|
167.1
|
46.4
|
5.7
|
5.0
|
667.4
|
31 March 2024
|
236.5
|
82.2
|
20.5
|
-
|
4.0
|
343.2
|
30 September 2024
|
117.7
|
30.2
|
2.9
|
-
|
-
|
150.8
|
|
|
|
|
|
|
|
|
|
|
8. Trade and other receivables
|
Unaudited
six months
ended 30
September
2024
|
Unaudited
six months
ended 30
September
2023
|
Audited year
ended
31 March
2024
|
|
£'m
|
£'m
|
£'m
|
Current
|
|
|
|
Trade receivables
|
55.0
|
81.4
|
69.2
|
Less: provision for impairment of
trade receivables
|
(0.4)
|
(1.8)
|
(2.1)
|
Trade receivables - net
|
54.6
|
79.6
|
67.1
|
Other receivables
|
1.3
|
4.6
|
1.0
|
Contract assets
|
3.2
|
5.3
|
3.1
|
Accrued income
|
16.8
|
29.5
|
20.9
|
Prepayments
|
7.8
|
12.3
|
5.9
|
Contingent consideration
receivable in less than one year
|
-
|
0.7
|
-
|
|
83.7
|
132.0
|
98.0
|
Non-current
|
|
|
|
Contingent consideration
receivable in more than one year
|
-
|
2.1
|
-
|
|
-
|
2.1
|
-
|
Contingent consideration
represented the divestment of non-core activities within the
Group's Air Quality business following the sale of Ductclean (UK)
Limited in March 2020 for a consideration of up to £7.0 million and
additional amounts receivable on projects concluded before the
transaction. These were financial assets classified as measured at
fair value through profit or loss. As at 31 March 2024, the
contingent consideration amounted to £nil as a settlement agreement
was made with the counterparty to settle the outstanding amount of
contingent consideration.
9. Net debt and borrowing facilities
|
Unaudited
six months
ended 30
September
2024
|
Unaudited
six months
ended 30
September
2023
|
Audited year
ended
31 March
2024
|
|
£'m
|
£'m
|
£'m
|
Continuing
Operations:
|
|
|
|
Cash at bank and in hand
|
30.8
|
36.3
|
-
|
Bank overdrafts due within one
year
|
-
|
-
|
(25.8)
|
Bank loans due within one
year
|
-
|
-
|
(206.0)
|
Bank loans due after one
year
|
-
|
(229.0)
|
-
|
Leases due within one
year
|
(12.5)
|
(9.4)
|
(9.4)
|
Leases due after one
year
|
(9.1)
|
(17.3)
|
(16.9)
|
Net cash/ (debt) for continuing operations
|
9.2
|
(219.4)
|
(258.1)
|
Discontinued
Operations:
|
|
|
|
Cash at bank and in hand
|
-
|
-
|
55.2
|
Leases due within one
year
|
-
|
-
|
(0.1)
|
Leases due after one
year
|
-
|
-
|
(0.2)
|
Net cash/ (debt) for total Group
|
9.2
|
(219.4)
|
(203.2)
|
Borrowing facilities
At 31 March 2024, the Group had a
£180 million revolving credit facility and an additional accordion
facility of £60 million with HSBC UK Bank plc, National Westminster
Bank plc, Citibank, N.A., Credit Industriel et Commercial, Fifth
Third Bank, and The Governor and Company of the Bank of Ireland
which was due to expire on 9 February 2025. £206 million of
the total facility was drawn as at 31 March 2024. All of the
Group's borrowings were in sterling.
Following the disposal of the GRC
business this facility was repaid in full on 5 June 2024 and fully
extinguished.
On 24 June 2024, the Group entered
into a new unsecured 3-year Revolving Credit Facility (RCF) for £50
million with Barclays Bank PLC and HSBC UK Bank plc. The RCF
includes two 1-year extension options and an uncommitted accordion
facility of £50 million.
10. Called up share capital and share
premium
Called up share capital
The issued ordinary share capital
is as follows:
|
Allotted, issued and fully
paid
|
Number of ordinary
shares
|
|
£'m
|
|
1
April 2023
|
47.9
|
95,882,065
|
Share Options ("SAYE
2020")
|
|
597,609
|
Share-based consideration for IMSM
acquisition
|
|
2,217
|
30 September 2023
|
48.2
|
96,481,891
|
Share Options ("SAYE
2020")
|
|
325,827
|
31 March 2024
|
48.4
|
96,807,718
|
Share Options ("SAYE
2020")
|
|
49,913
|
Marlowe plc Long Term Incentive
Plan 2019
|
|
92,975
|
Cancellation of ordinary
shares
|
|
(8,946,087)
|
30 September 2024
|
44.0
|
88,004,519
|
Share premium
In year ending 31 March 2024, the
Company gained shareholder and court approval to release £384.9
million from the share premium account to retained
earnings.
11. Cash generated from operations
|
Unaudited
six months
ended 30
September
2024
|
Unaudited
six months
ended 30
September
2023
|
Audited year
ended
31 March
2024
|
|
£'m
|
£'m
|
£'m
|
|
|
|
|
Profit/(Loss) before
tax
|
161.7
|
(8.9)
|
(10.9)
|
Depreciation of property, plant
and equipment, depreciation of right-of-use assets and amortisation
of non-acquisition intangibles
|
9.0
|
10.0
|
20.9
|
Amortisation of acquired
intangibles
|
6.5
|
12.8
|
25.6
|
Loss on sale of fixed
assets
|
-
|
-
|
(0.2)
|
Share based payments (excluding
SAYE schemes)
|
0.4
|
0.8
|
(0.8)
|
Fair value losses in contingent
consideration and acquisition related incentive schemes
|
-
|
3.2
|
5.0
|
Gain recognised on disposal of
discontinued operations
|
(165.9)
|
-
|
|
Net finance costs
|
3.3
|
8.9
|
20.5
|
Decrease/(increase) in
inventories
|
0.4
|
(0.2)
|
-
|
Increase in trade and other
receivables
|
(8.3)
|
(10.2)
|
(1.2)
|
(Decrease)/increase in trade and
other payables
|
(0.7)
|
0.3
|
(1.1)
|
Cash generated from operations
|
6.4
|
16.7
|
57.8
|
12. Related party transactions
There were no related party transactions during the current or
prior period.
13.
Post balance sheet events
Since the 30 September 2024, as at 4
December 2024, Marlowe has purchased a further 2,945,529 ordinary
shares for a consideration of £10.0 million at a volume weighted
average price of 339.50 pence per ordinary share.